INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2022

Daily vitamin D supplementation reduced cancer mortality overall and cancer incidence specifically in normal-weight individuals.

A meta-analysis evaluated RCTs to assess whether vitamin D dosing strategies and adiposity affect total cancer outcomes. Across 12 trials, vitamin D supplementation did not reduce total cancer incidence overall (SRR 0.99, 95% CI 0.94-1.03), though daily dosing showed an inverse association among normal-weight individuals (SRR 0.76, 95% CI 0.64-0.90) but not overweight/obese participants. For total cancer mortality (6 trials), the overall SRR was 0.92 (95% CI 0.82-1.03), but daily supplementation significantly reduced mortality (SRR 0.87, 95% CI 0.78-0.96) while infrequent large-bolus dosing did not.

Study type
Meta-analysis of randomized controlled trials
Who was studied
Participants across 12 RCTs for incidence and 6 RCTs for mortality
What was measured
Total cancer incidence and total cancer mortality

THE PAPER

Vitamin D supplementation and total cancer incidence and mortality by daily vs. infrequent large-bolus dosing strategies: a meta-analysis of randomised controlled trials.

Keum N, Chen QY, Lee DH, Manson JE, Giovannucci E. Br J Cancer, 2022.

PubMed 35676320 ↗DOI 10.1002/1878-0261.12924 ↗

CancerNutrients & adequacyWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.